Your review * I havent lost much weight, but I have had only 5 injections
Again, the answer is: We dont know
We urge everyone to be cautious of any brand claiming endorsement by Obesity Canada or its leadership
Bearing in mind that a recent review stated that nonalcoholic fatty liver disease (NAFLD) is very frequent in PCOS patients, and that the combination of PCOS with obesity and IR is a dangerous cocktail that, over time, triggers not only NALFD but also the occurrence of type II diabetes (40, 41), as an additional feature, we also evaluated the HIE in our patients (23)
Key takeaways GLP-1 agonists are FDA-approved drugs for Type 2 diabetes or weight management
Many people labelled as non-responders to GLP-1 receptor agonists such as semaglutide do not take the medication correctly or discontinue treatment before adequate therapeutic effect can be achieved